Quantitative SPECT/CT Imaging of 177Lu with In Vivo Validation in Patients Undergoing Peptide Receptor Radionuclide Therapy

被引：0
|
作者：
J. C. Sanders
T. Kuwert
J. Hornegger
P. Ritt
机构：
[1] University of Erlangen-Nuremberg,Pattern Recognition Lab, Department of Computer Science
[2] University of Erlangen-Nuremberg,Clinic of Nuclear Medicine, University Hospital Erlangen
来源：
Molecular Imaging and Biology | 2015年 / 17卷
关键词：
Quantitative SPECT; [; Lu]DOTATATE; Peptide receptor radionuclide therapy; Dosimetry;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：585 / 593
页数：8
相关论文
共 50 条
  • [11] The technologist role in 177Lu dosimetry for PRRT (Peptide Receptor Radionuclide Therapy)
    Leoni, E.
    Filice, A.
    Palmieri, A.
    Ghiraldini, G.
    Fioroni, F.
    Grassi, E.
    Cola, S.
    Versari, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S850 - S851
  • [12] Feasibility of simplifying renal dosimetry in 177Lu peptide receptor radionuclide therapy
    Anna Sundlöv
    Johan Gustafsson
    Gustav Brolin
    Nadja Mortensen
    Rebecca Hermann
    Peter Bernhardt
    Johanna Svensson
    Michael Ljungberg
    Jan Tennvall
    Katarina Sjögreen Gleisner
    EJNMMI Physics, 5
  • [13] A Rapid and Safe Infusion Protocol for 177Lu Peptide Receptor Radionuclide Therapy
    Ebbers, Sander C.
    Barentsz, Maarten W.
    de Keizer, Bart
    Krijger, Gerard C.
    Lam, Marnix G. E. H.
    Braat, Arthur J. A. T.
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (06) : 816 - 822
  • [14] 177Lu DOTATATE nanoparticles: A therapeutic option for peptide receptor radionuclide therapy
    Arora, Geetanjali
    Shukla, Jaya
    Ghosh, Sourabh
    Malhotra, Arun
    Bandohpadhyaya, Guru
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [15] DNA damage in blood lymphocytes in patients after 177Lu peptide receptor radionuclide therapy
    Uta Eberlein
    Carina Nowak
    Christina Bluemel
    Andreas Konrad Buck
    Rudolf Alexander Werner
    Harry Scherthan
    Michael Lassmann
    European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42 : 1739 - 1749
  • [16] DNA damage in blood lymphocytes in patients after 177Lu peptide receptor radionuclide therapy
    Eberlein, Uta
    Nowak, Carina
    Bluemel, Christina
    Buck, Andreas Konrad
    Werner, Rudolf Alexander
    Scherthan, Harry
    Lassmann, Michael
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (11) : 1739 - 1749
  • [17] Quantitative 177Lu SPECT (QSPECT) imaging using a commercially available SPECT/CT system
    Beauregard, Jean-Mathieu
    Hofman, Michael S.
    Pereira, Jucilene M.
    Eu, Peter
    Hicks, Rodney J.
    CANCER IMAGING, 2011, 11 (01) : 56 - 66
  • [18] Absolute SPECT/CTcalibration for dosimetry in 177Lu targeted radionuclide therapy
    Fioroni, F.
    Grassi, E.
    Ferri, V.
    Antonio, S. Marco
    Angelina, F.
    Versari, A.
    Iori, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S751 - S751
  • [19] Assessment of the quantitative accuracy of 177Lu SPECT reconstruction for Peptide Receptor Radiotherapy (PRRT)
    Mirando, D.
    Kruzer, A.
    Nelson, A. S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S582 - S583
  • [20] STABILITY STUDIES OF [177LU]-DOTATATE ([177LU]-LUTATE) FOR PEPTIDE RECEPTOR RADIONUCLIDE THERAPY USING CARRIER ADDED AND NON-CARRIER ADDED [177LU]-LUTETIUM
    Yasmin, L.
    Aslani, A.
    Bailey, D.
    INTERNAL MEDICINE JOURNAL, 2019, 49 : 41 - 41
12345